Liquidia Co. (NASDAQ:LQDA) CEO Roger Jeffs Purchases 28,000 Shares

Liquidia Co. (NASDAQ:LQDAGet Rating) CEO Roger Jeffs acquired 28,000 shares of the company’s stock in a transaction on Tuesday, May 24th. The stock was acquired at an average cost of $3.53 per share, for a total transaction of $98,840.00. Following the completion of the acquisition, the chief executive officer now owns 46,595 shares of the company’s stock, valued at approximately $164,480.35. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shares of LQDA stock traded up $0.28 on Wednesday, hitting $3.65. 1,538,792 shares of the stock traded hands, compared to its average volume of 707,687. The stock has a market capitalization of $234.86 million, a PE ratio of -4.56 and a beta of 0.33. The firm’s 50-day moving average price is $5.99 and its two-hundred day moving average price is $5.59. Liquidia Co. has a twelve month low of $2.25 and a twelve month high of $7.78.

Liquidia (NASDAQ:LQDAGet Rating) last released its quarterly earnings results on Thursday, May 12th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.10). During the same quarter in the previous year, the firm earned ($0.21) EPS. As a group, equities research analysts expect that Liquidia Co. will post -0.98 EPS for the current fiscal year.

Several brokerages have recently issued reports on LQDA. HC Wainwright lifted their target price on shares of Liquidia from $6.00 to $16.00 and gave the company a “buy” rating in a research report on Thursday, February 3rd. Zacks Investment Research downgraded Liquidia from a “hold” rating to a “sell” rating in a research report on Wednesday, April 6th.

Several large investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. increased its position in shares of Liquidia by 16.3% during the 4th quarter. Goldman Sachs Group Inc. now owns 18,240 shares of the company’s stock worth $89,000 after purchasing an additional 2,557 shares during the last quarter. Marshall Wace LLP purchased a new position in shares of Liquidia during the 1st quarter worth approximately $32,000. BlackRock Inc. increased its stake in Liquidia by 0.4% during the 1st quarter. BlackRock Inc. now owns 846,385 shares of the company’s stock worth $6,077,000 after buying an additional 3,042 shares during the period. Schonfeld Strategic Advisors LLC increased its stake in Liquidia by 17.2% during the 3rd quarter. Schonfeld Strategic Advisors LLC now owns 25,200 shares of the company’s stock worth $69,000 after buying an additional 3,700 shares during the period. Finally, UBS Group AG grew its holdings in Liquidia by 205.4% during the 3rd quarter. UBS Group AG now owns 10,151 shares of the company’s stock worth $28,000 after acquiring an additional 6,827 shares in the last quarter. 27.68% of the stock is owned by hedge funds and other institutional investors.

Liquidia Company Profile (Get Rating)

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension.

Further Reading

Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.